Proscia Offers Concentriq Dx for Remote Use in Clinical Practice During COVID-19

The FDA has issued guidance aimed at expanding the use of remote digital pathology devices during the COVID-19 pandemic.

In response to the FDA’s guidance, Proscia announced today that we are now offering our Concentriq Dx digital pathology software for remote use in clinical practice in the United States. Concentriq Dx is an image management and workflow solution that enables pathologists to read cases from remote locations, including home offices, using an Internet browser. It is CE-marked for use in primary diagnosis in Europe.

You can learn more about this new availability of Concentriq Dx in our press release.

Proscia is committed to helping the pathology community maintain operations and serve patients with digital pathology, and we are here to get you up-and-running quickly. Please reach out to me directly if you’re interesting in getting started.

Source: Proscia